The market is broadcasting extreme distortion here: a trailing P/E of 500+ alongside a Forward P/E of 10.3 tells you earnings are expected to normalize violently, yet the Altman Z-Score of 1.3 signals balance sheet stress that cannot be ignored. A PEG Forward of 0.8 suggests theoretical undervaluation relative to growth, but that signal is compromised by razor-thin Operating Margin of 0.10% and a meager 3.10% Return on Equity. This is not a clean growth story—it’s a cyclical balance sheet gamble priced as if earnings recovery is imminent while financial fragility remains real. The stock looks statistically cheap on forward metrics, but safety is questionable given solvency indicators.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.